Audiomedica.com

Ribociclib Aids First-Line Endocrine Therapy in Premenopausal Advanced Breast Cancer

Informações:

Sinopsis

BARCELONA—More pre-menopausal women who have estrogen receptor (ER) positive advanced breast cancer could be spared chemotherapy—according to latest findings from the MONALEESA-7 double-blind randomized phase 3 trial in which either placebo (PBO) or the cyclin-dependent kinase (CDK) 4/6 inhibitor ribociclib …Nadia Harbeck with Emiel Rutgers AJO PRODUCTION MASTER